Pharma 4.0 Market, Global Outlook and Forecast 2022-2028

June 2022 | 109 pages | ID: P7A4D79BCB72EN
Market Monitor Global

Abstracts

Pharma 4.0 is a holistic operating model for pharmaceutical factories and supply chains of the future based on Industry 4.0 capabilities, digital maturity, and data integrity by design.Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. In practical terms, it means more connectivity, more productivity, simplified compliance, and the marshaling of production information to respond to problems as they emerge.

This report contains market size and forecasts of Pharma 4.0 in Global, including the following market information:

Global Pharma 4.0 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pharma 4.0 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cloud Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pharma 4.0 include Pfizer Inc, Abbott Laboratories, GE Healthcare, Boston Scientific, Medtronic Plc., Lonza Group AG, GlaxoSmithKline plc., Koninklijke Philips N.V. and Glatt GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma 4.0 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pharma 4.0 Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pharma 4.0 Market Segment Percentages, by Type, 2021 (%)

• Cloud
• On-premise

Global Pharma 4.0 Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pharma 4.0 Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical Industry
• IoT Industry
• Medical Equipment Industry
• Others

Global Pharma 4.0 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pharma 4.0 Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pharma 4.0 revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pharma 4.0 revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer Inc
• Abbott Laboratories
• GE Healthcare
• Boston Scientific
• Medtronic Plc.
• Lonza Group AG
• GlaxoSmithKline plc.
• Koninklijke Philips N.V.
• Glatt GmbH
• Vertex
• Johnson & Johnson
• Goodly Innovations
• QbDVision
• Electrosan
• GoSilico
• Smart Factory

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pharma 4.0 Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pharma 4.0 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHARMA 4.0 OVERALL MARKET SIZE

2.1 Global Pharma 4.0 Market Size: 2021 VS 2028
2.2 Global Pharma 4.0 Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pharma 4.0 Players in Global Market
3.2 Top Global Pharma 4.0 Companies Ranked by Revenue
3.3 Global Pharma 4.0 Revenue by Companies
3.4 Top 3 and Top 5 Pharma 4.0 Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharma 4.0 Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharma 4.0 Players in Global Market
  3.6.1 List of Global Tier 1 Pharma 4.0 Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pharma 4.0 Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pharma 4.0 Market Size Markets, 2021 & 2028
  4.1.2 Cloud
  4.1.3 On-premise
4.2 By Type - Global Pharma 4.0 Revenue & Forecasts
  4.2.1 By Type - Global Pharma 4.0 Revenue, 2017-2022
  4.2.2 By Type - Global Pharma 4.0 Revenue, 2023-2028
  4.2.3 By Type - Global Pharma 4.0 Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pharma 4.0 Market Size, 2021 & 2028
  5.1.2 Pharmaceutical Industry
  5.1.3 IoT Industry
  5.1.4 Medical Equipment Industry
  5.1.5 Others
5.2 By Application - Global Pharma 4.0 Revenue & Forecasts
  5.2.1 By Application - Global Pharma 4.0 Revenue, 2017-2022
  5.2.2 By Application - Global Pharma 4.0 Revenue, 2023-2028
  5.2.3 By Application - Global Pharma 4.0 Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pharma 4.0 Market Size, 2021 & 2028
6.2 By Region - Global Pharma 4.0 Revenue & Forecasts
  6.2.1 By Region - Global Pharma 4.0 Revenue, 2017-2022
  6.2.2 By Region - Global Pharma 4.0 Revenue, 2023-2028
  6.2.3 By Region - Global Pharma 4.0 Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pharma 4.0 Revenue, 2017-2028
  6.3.2 US Pharma 4.0 Market Size, 2017-2028
  6.3.3 Canada Pharma 4.0 Market Size, 2017-2028
  6.3.4 Mexico Pharma 4.0 Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pharma 4.0 Revenue, 2017-2028
  6.4.2 Germany Pharma 4.0 Market Size, 2017-2028
  6.4.3 France Pharma 4.0 Market Size, 2017-2028
  6.4.4 U.K. Pharma 4.0 Market Size, 2017-2028
  6.4.5 Italy Pharma 4.0 Market Size, 2017-2028
  6.4.6 Russia Pharma 4.0 Market Size, 2017-2028
  6.4.7 Nordic Countries Pharma 4.0 Market Size, 2017-2028
  6.4.8 Benelux Pharma 4.0 Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pharma 4.0 Revenue, 2017-2028
  6.5.2 China Pharma 4.0 Market Size, 2017-2028
  6.5.3 Japan Pharma 4.0 Market Size, 2017-2028
  6.5.4 South Korea Pharma 4.0 Market Size, 2017-2028
  6.5.5 Southeast Asia Pharma 4.0 Market Size, 2017-2028
  6.5.6 India Pharma 4.0 Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pharma 4.0 Revenue, 2017-2028
  6.6.2 Brazil Pharma 4.0 Market Size, 2017-2028
  6.6.3 Argentina Pharma 4.0 Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pharma 4.0 Revenue, 2017-2028
  6.7.2 Turkey Pharma 4.0 Market Size, 2017-2028
  6.7.3 Israel Pharma 4.0 Market Size, 2017-2028
  6.7.4 Saudi Arabia Pharma 4.0 Market Size, 2017-2028
  6.7.5 UAE Pharma 4.0 Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer Inc
  7.1.1 Pfizer Inc Corporate Summary
  7.1.2 Pfizer Inc Business Overview
  7.1.3 Pfizer Inc Pharma 4.0 Major Product Offerings
  7.1.4 Pfizer Inc Pharma 4.0 Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Inc Key News
7.2 Abbott Laboratories
  7.2.1 Abbott Laboratories Corporate Summary
  7.2.2 Abbott Laboratories Business Overview
  7.2.3 Abbott Laboratories Pharma 4.0 Major Product Offerings
  7.2.4 Abbott Laboratories Pharma 4.0 Revenue in Global Market (2017-2022)
  7.2.5 Abbott Laboratories Key News
7.3 GE Healthcare
  7.3.1 GE Healthcare Corporate Summary
  7.3.2 GE Healthcare Business Overview
  7.3.3 GE Healthcare Pharma 4.0 Major Product Offerings
  7.3.4 GE Healthcare Pharma 4.0 Revenue in Global Market (2017-2022)
  7.3.5 GE Healthcare Key News
7.4 Boston Scientific
  7.4.1 Boston Scientific Corporate Summary
  7.4.2 Boston Scientific Business Overview
  7.4.3 Boston Scientific Pharma 4.0 Major Product Offerings
  7.4.4 Boston Scientific Pharma 4.0 Revenue in Global Market (2017-2022)
  7.4.5 Boston Scientific Key News
7.5 Medtronic Plc.
  7.5.1 Medtronic Plc. Corporate Summary
  7.5.2 Medtronic Plc. Business Overview
  7.5.3 Medtronic Plc. Pharma 4.0 Major Product Offerings
  7.5.4 Medtronic Plc. Pharma 4.0 Revenue in Global Market (2017-2022)
  7.5.5 Medtronic Plc. Key News
7.6 Lonza Group AG
  7.6.1 Lonza Group AG Corporate Summary
  7.6.2 Lonza Group AG Business Overview
  7.6.3 Lonza Group AG Pharma 4.0 Major Product Offerings
  7.6.4 Lonza Group AG Pharma 4.0 Revenue in Global Market (2017-2022)
  7.6.5 Lonza Group AG Key News
7.7 GlaxoSmithKline plc.
  7.7.1 GlaxoSmithKline plc. Corporate Summary
  7.7.2 GlaxoSmithKline plc. Business Overview
  7.7.3 GlaxoSmithKline plc. Pharma 4.0 Major Product Offerings
  7.7.4 GlaxoSmithKline plc. Pharma 4.0 Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline plc. Key News
7.8 Koninklijke Philips N.V.
  7.8.1 Koninklijke Philips N.V. Corporate Summary
  7.8.2 Koninklijke Philips N.V. Business Overview
  7.8.3 Koninklijke Philips N.V. Pharma 4.0 Major Product Offerings
  7.8.4 Koninklijke Philips N.V. Pharma 4.0 Revenue in Global Market (2017-2022)
  7.8.5 Koninklijke Philips N.V. Key News
7.9 Glatt GmbH
  7.9.1 Glatt GmbH Corporate Summary
  7.9.2 Glatt GmbH Business Overview
  7.9.3 Glatt GmbH Pharma 4.0 Major Product Offerings
  7.9.4 Glatt GmbH Pharma 4.0 Revenue in Global Market (2017-2022)
  7.9.5 Glatt GmbH Key News
7.10 Vertex
  7.10.1 Vertex Corporate Summary
  7.10.2 Vertex Business Overview
  7.10.3 Vertex Pharma 4.0 Major Product Offerings
  7.10.4 Vertex Pharma 4.0 Revenue in Global Market (2017-2022)
  7.10.5 Vertex Key News
7.11 Johnson & Johnson
  7.11.1 Johnson & Johnson Corporate Summary
  7.11.2 Johnson & Johnson Business Overview
  7.11.3 Johnson & Johnson Pharma 4.0 Major Product Offerings
  7.11.4 Johnson & Johnson Pharma 4.0 Revenue in Global Market (2017-2022)
  7.11.5 Johnson & Johnson Key News
7.12 Goodly Innovations
  7.12.1 Goodly Innovations Corporate Summary
  7.12.2 Goodly Innovations Business Overview
  7.12.3 Goodly Innovations Pharma 4.0 Major Product Offerings
  7.12.4 Goodly Innovations Pharma 4.0 Revenue in Global Market (2017-2022)
  7.12.5 Goodly Innovations Key News
7.13 QbDVision
  7.13.1 QbDVision Corporate Summary
  7.13.2 QbDVision Business Overview
  7.13.3 QbDVision Pharma 4.0 Major Product Offerings
  7.13.4 QbDVision Pharma 4.0 Revenue in Global Market (2017-2022)
  7.13.5 QbDVision Key News
7.14 Electrosan
  7.14.1 Electrosan Corporate Summary
  7.14.2 Electrosan Business Overview
  7.14.3 Electrosan Pharma 4.0 Major Product Offerings
  7.14.4 Electrosan Pharma 4.0 Revenue in Global Market (2017-2022)
  7.14.5 Electrosan Key News
7.15 GoSilico
  7.15.1 GoSilico Corporate Summary
  7.15.2 GoSilico Business Overview
  7.15.3 GoSilico Pharma 4.0 Major Product Offerings
  7.15.4 GoSilico Pharma 4.0 Revenue in Global Market (2017-2022)
  7.15.5 GoSilico Key News
7.16 Smart Factory
  7.16.1 Smart Factory Corporate Summary
  7.16.2 Smart Factory Business Overview
  7.16.3 Smart Factory Pharma 4.0 Major Product Offerings
  7.16.4 Smart Factory Pharma 4.0 Revenue in Global Market (2017-2022)
  7.16.5 Smart Factory Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pharma 4.0 Market Opportunities & Trends in Global Market
Table 2. Pharma 4.0 Market Drivers in Global Market
Table 3. Pharma 4.0 Market Restraints in Global Market
Table 4. Key Players of Pharma 4.0 in Global Market
Table 5. Top Pharma 4.0 Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharma 4.0 Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharma 4.0 Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharma 4.0 Product Type
Table 9. List of Global Tier 1 Pharma 4.0 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharma 4.0 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharma 4.0 Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharma 4.0 Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharma 4.0 Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharma 4.0 Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharma 4.0 Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharma 4.0 Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharma 4.0 Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharma 4.0 Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharma 4.0 Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharma 4.0 Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharma 4.0 Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharma 4.0 Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharma 4.0 Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharma 4.0 Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharma 4.0 Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharma 4.0 Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharma 4.0 Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharma 4.0 Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharma 4.0 Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Inc Corporate Summary
Table 31. Pfizer Inc Pharma 4.0 Product Offerings
Table 32. Pfizer Inc Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Pharma 4.0 Product Offerings
Table 35. Abbott Laboratories Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 36. GE Healthcare Corporate Summary
Table 37. GE Healthcare Pharma 4.0 Product Offerings
Table 38. GE Healthcare Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 39. Boston Scientific Corporate Summary
Table 40. Boston Scientific Pharma 4.0 Product Offerings
Table 41. Boston Scientific Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 42. Medtronic Plc. Corporate Summary
Table 43. Medtronic Plc. Pharma 4.0 Product Offerings
Table 44. Medtronic Plc. Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 45. Lonza Group AG Corporate Summary
Table 46. Lonza Group AG Pharma 4.0 Product Offerings
Table 47. Lonza Group AG Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline plc. Corporate Summary
Table 49. GlaxoSmithKline plc. Pharma 4.0 Product Offerings
Table 50. GlaxoSmithKline plc. Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 51. Koninklijke Philips N.V. Corporate Summary
Table 52. Koninklijke Philips N.V. Pharma 4.0 Product Offerings
Table 53. Koninklijke Philips N.V. Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 54. Glatt GmbH Corporate Summary
Table 55. Glatt GmbH Pharma 4.0 Product Offerings
Table 56. Glatt GmbH Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 57. Vertex Corporate Summary
Table 58. Vertex Pharma 4.0 Product Offerings
Table 59. Vertex Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 60. Johnson & Johnson Corporate Summary
Table 61. Johnson & Johnson Pharma 4.0 Product Offerings
Table 62. Johnson & Johnson Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 63. Goodly Innovations Corporate Summary
Table 64. Goodly Innovations Pharma 4.0 Product Offerings
Table 65. Goodly Innovations Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 66. QbDVision Corporate Summary
Table 67. QbDVision Pharma 4.0 Product Offerings
Table 68. QbDVision Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 69. Electrosan Corporate Summary
Table 70. Electrosan Pharma 4.0 Product Offerings
Table 71. Electrosan Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 72. GoSilico Corporate Summary
Table 73. GoSilico Pharma 4.0 Product Offerings
Table 74. GoSilico Pharma 4.0 Revenue (US$, Mn), (2017-2022)
Table 75. Smart Factory Corporate Summary
Table 76. Smart Factory Pharma 4.0 Product Offerings
Table 77. Smart Factory Pharma 4.0 Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pharma 4.0 Segment by Type in 2021
Figure 2. Pharma 4.0 Segment by Application in 2021
Figure 3. Global Pharma 4.0 Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharma 4.0 Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharma 4.0 Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharma 4.0 Revenue in 2021
Figure 8. By Type - Global Pharma 4.0 Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharma 4.0 Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharma 4.0 Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharma 4.0 Revenue Market Share, 2017-2028
Figure 12. US Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharma 4.0 Revenue Market Share, 2017-2028
Figure 16. Germany Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharma 4.0 Revenue Market Share, 2017-2028
Figure 24. China Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharma 4.0 Revenue Market Share, 2017-2028
Figure 30. Brazil Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharma 4.0 Revenue Market Share, 2017-2028
Figure 33. Turkey Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharma 4.0 Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Inc Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Laboratories Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GE Healthcare Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boston Scientific Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medtronic Plc. Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lonza Group AG Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline plc. Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Koninklijke Philips N.V. Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Glatt GmbH Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Vertex Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Johnson & Johnson Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Goodly Innovations Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. QbDVision Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Electrosan Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. GoSilico Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Smart Factory Pharma 4.0 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)